|
Clinical trials Observational study (Cohort, Case control)
Citations 291-300 of 351 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil
- Wengui Yu and Steven H. Horowitz
Neurology 2003; 60: 120-121.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1
- A. Gupta, B.H. Cohen, P. Ruggieri, R.J. Packer, and P.C. Phillips
Neurology 2003; 60: 130-132.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
No additional benefit of HRT on response to rivastigmine in menopausal women with AD
- A.S. Rigaud, G. André, B. Vellas, J. Touchon, and J.J. Pere
Neurology 2003; 60: 148-a-149-a.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri
- Elie Louis, Florence Keime-Guibert, Jean-Yves Delattre, and Marc Sanson
Neurology 2003; 60: 151.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD
- E. Lagrange, P. Krack, E. Moro, C. Ardouin, N. Van Blercom, S. Chabardes, A.L. Benabid, and P. Pollak
Neurology 2002; 59: 1976-1978.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Gabapentin in late-onset poststroke seizures
- J. Alvarez-Sabín, J. Montaner, L. Padró, C. A. Molina, R. Rovira, A. Codina, and M. Quintana
Neurology 2002; 59: 1991-1993.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Refractory neurosarcoidosis responding to infliximab
- J.A. Pettersen, D.W. Zochodne, R.B. Bell, L. Martin, and M.D. Hill
Neurology 2002; 59: 1660.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Intratympanic gentamicin injections for Meniere disease Vestibular hair cell impairment and regeneration
- C. de Waele, R. Meguenni, G. Freyss, F. Zamith, N. Bellalimat, P.P. Vidal, and P. Tran Ba Huy
Neurology 2002; 59: 1442-1444.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
N-acetylcysteine and Unverricht–Lundborg disease Variable response and possible side effects
- M.J.J. Edwards, I.P. Hargreaves, S.J.R. Heales, S.J. Jones, V. Ramachandran, K.P. Bhatia, and S. Sisodiya
Neurology 2002; 59: 1447-1449.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cerebrospinal fluid shunting for Alzheimer’s disease?
- David A. Bennett and Michael P. McDermott
Neurology 2002; 59: 1126-1127.
[Full text]
[PDF]
|
|
